跳至主要内容
临床试验/CTRI/2025/07/091359
CTRI/2025/07/091359尚未招募3 期

A Comparative Study of Timing of Intravenous Oxytocin Administration To Minimize Blood Loss During First Trimester Evacuation (Surgical Termination of Pregnancy)

SMIMS1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年8月21日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Administration of oxytocin prior to suction and evacuationof First trimester abortion is more efficacious in reducing blood loss.

研究概览

简要总结

This comparative study investigates the optimal timing of intravenous oxytocin administration to reduce blood loss during first- rimester surgical termination of pregnancy evacuation. Oxytocin, a uterotonic agent is commonly used to promote uterine contraction and minimize hemorrhage. The study evaluates the effectiveness of administering oxytocin at different time points 10 minute before and after 10 minute of starting the procedure on post-procedure blood loss. The study supports adjusting the timing of oxytocin infusion as a simple, cost effective strategy to improve safety outcomes during early surgical abortions.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • All antenatal women with confirmed first trimester abortion.

排除标准

  • Prior anticoagulant treatment or history of coagulopathy,
  • Patients who donot give consent to participate in this study.

结局指标

主要结局

Administration of oxytocin prior to suction and evacuationof First trimester abortion is more efficacious in reducing blood loss.

时间窗: One day

次要结局

未报告次要终点

研究者

发起方
SMIMS
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Hanswahini Garg

Sikkim Manipal Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验